Sponsor: Molecular MDCodevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.
Sponsor: MolecularMDIn this eBook learn how MolecularMD is harnessing the company's unique capabilities to address diagnostic needs within immuno-oncology.
Sponsor: DNAnexusThe challenges of incorporating NGS into clinical trials is being addressed through the adoption of robust technology solutions.
Sponsor: MolecularMDDownload this eBook to learn how MolecularMD helped usher in a new era of CML treatment now prescribed by progressive clinicians.
Sponsor: Advanced Analytical2015 was a phenomenal year full of new developments for the structures and mechanisms of CRISPR systems.
Sponsor: PerkinElmerRNA and sequencing technologies have the potential to unlock the mystery of our every dynamic transcriptome.